Surgical Associates - Where surgery is more than just science, it is an art.

Uterine Fibroid Embolization

Uterine Fibroid Embolization (UFE) is an approved, non-surgical treatment that may be a better option for many women with uterine fibroids than conventional treatments that remove the uterus (hysterectomy) or scrape or burn the fibroids in the uterus (myomectomy). Unlike surgery, UFE does not require general anesthesia, stitches, scarring, blood loss, removal of the uterus or burning or scraping of the uterine lining. UFE has several advantages over the other treatments for uterine fibroids.

It involves no blood loss, no stitches or surgical incision (only a small nick in the skin), no abdominal scar, no general anesthesia, no prolonged hospital stay, and no burning or scraping the lining of the uterus.
Uterine fibroid embolization requires much less time off work than hysterectomy (a few days to a week, versus six weeks or more).
One advantage compared to myomectomy is that uterine fibroid embolization can be used to treat all fibroids at the same time, regardless of their size or location in the uterus.
Unlike treatment with Lupron, premature symptoms of menopause are not usually induced. The materials used for uterine fibroid embolization are well tolerated and FDA-approved for embolization.

In some cases, UFE can be used prior to a planned hysterectomy

In the fall of 2006, Dr Gary Grover began offering UFE procedures after referral from the patient’s PCP or GYN. Uterine fibroid embolization was first used to limit blood loss during surgical removal of fibroid tumors. It was found that after embolization and while awaiting surgery, many patients no longer had symptoms, and frequently the operation itself proved not to be necessary. Today uterine fibroid embolization is used as a stand-alone treatment for women who have symptom-producing uterine fibroids.


	HOME BOARD-CERTIFIED SURGEONS Gary Grover M.D. Laeeq Ahmad, M.D. Benjamin H. Finder, M.D. Pam Odle, CRNP Tong Ma, M.D. Suryakant Patel, M.D. James Tzeng, M.D., Ph.D. Robert Wagner, D.O. Jacques Zephirin, M.D. LOCATIONS MEDICAL PROCEDURES Vascular Therapy Laser Vein Care Wound Care Heartburn & Reflux Center Total Breast Care Advanced Laparoscopic Care Uterine Fibroid Embolization General Surgery
	Uterine Fibroid Embolization Uterine Fibroid Embolization (UFE) is an approved, non-surgical treatment that may be a better option for many women with uterine fibroids than conventional treatments that remove the uterus (hysterectomy) or scrape or burn the fibroids in the uterus (myomectomy). Unlike surgery, UFE does not require general anesthesia, stitches, scarring, blood loss, removal of the uterus or burning or scraping of the uterine lining. UFE has several advantages over the other treatments for uterine fibroids. It involves no blood loss, no stitches or surgical incision (only a small nick in the skin), no abdominal scar, no general anesthesia, no prolonged hospital stay, and no burning or scraping the lining of the uterus. Uterine fibroid embolization requires much less time off work than hysterectomy (a few days to a week, versus six weeks or more). One advantage compared to myomectomy is that uterine fibroid embolization can be used to treat all fibroids at the same time, regardless of their size or location in the uterus. Unlike treatment with Lupron, premature symptoms of menopause are not usually induced. The materials used for uterine fibroid embolization are well tolerated and FDA-approved for embolization. In some cases, UFE can be used prior to a planned hysterectomy In the fall of 2006, Dr Gary Grover began offering UFE procedures after referral from the patient’s PCP or GYN. Uterine fibroid embolization was first used to limit blood loss during surgical removal of fibroid tumors. It was found that after embolization and while awaiting surgery, many patients no longer had symptoms, and frequently the operation itself proved not to be necessary. Today uterine fibroid embolization is used as a stand-alone treatment for women who have symptom-producing uterine fibroids.